10.1038/s41398-019-0457-y 189
The researchers performed a secondary analysis of the LEADER trial to investigate the occurrence of gallbladder complications as a side effect for liraglutide
Conclusions/interpretation Our findings highlight a synergistic interaction between GLP-1RA and Akk11, likely mediated through microbiota remodeling and parallel improvements in lipid metabolism across intestinal, hepatic, and adipose compartments
New Delhi: People taking GLP-1 receptor agonist drugsmedications that help control blood sugar and reduce appetiteespecially semaglutide, face a modestly increased risk of developing a rare and potentially blinding eye disorder compared to those on a different class of diabetes medication, a large study has found
It Just Needs the Signals Restored
Remember that successful weight management is a journey, not a destination